To acquire insights into the status of AAT in real samples, aliquots of this inhibitor purified from plasma and BALf (of healthy and COVID-19 patients) as mentioned above, were loaded on RP-HPLC in parallel with normal and in vitro oxidized standard AAT. The gene discussed is SERPINA1; the disease is COVID-19.